Atlas Trials

Study to Evaluate Whether a Medication Event Monitoring System (MEMS) Can Improve Adherence to Tecfidera Treatment in Multiple Sclerosis Patients.

Clinical trial NCT02343159 · TERMINATED

Trial details

NCT number
NCT02343159
Sponsor
Biogen
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2015-02-28
Primary completion
2016-04-15
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.